Insider Transactions in Q4 2022 at Abiomed Inc (ABMD)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2022
|
Matthew T. Plano VP, GLOBAL OPERATIONS |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,406
-100.0%
|
-
|
|
Dec 22
2022
|
Todd A Trapp VICE PRESIDENT, CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,166
-100.0%
|
-
|
|
Dec 22
2022
|
Dorothy E Puhy |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,590
-100.0%
|
-
|
|
Dec 22
2022
|
Martin P Sutter |
SELL
Sale (or disposition) back to the issuer
|
Direct |
123,370
-100.0%
|
-
|
|
Dec 22
2022
|
Marc A Began VP & GENERAL COUNSEL |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,237
-100.0%
|
-
|
|
Dec 22
2022
|
Andrew J Greenfield VP, CHIEF COMMERCIAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,484
-100.0%
|
-
|
|
Dec 22
2022
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
243,962
-100.0%
|
-
|
|
Dec 22
2022
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
166,670
-100.0%
|
-
|
|
Dec 22
2022
|
Chris Van Gorder |
BUY
Grant, award, or other acquisition
|
Direct |
7,410
+100.0%
|
-
|
|
Dec 22
2022
|
Myron L Rolle |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,721
-100.0%
|
-
|
|
Dec 22
2022
|
Paul Thomas |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,357
-100.0%
|
-
|
|
Dec 22
2022
|
Paula A Johnson |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,659
-100.0%
|
-
|
|
Dec 16
2022
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.0%
|
-
|
|
Dec 16
2022
|
Andrew J Greenfield VP, CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.09%
|
-
|
|
Nov 16
2022
|
Martin P Sutter |
SELL
Open market or private sale
|
Direct |
2,000
-0.82%
|
$750,000
$375.11 P/Share
|
|
Nov 15
2022
|
Martin P Sutter |
SELL
Open market or private sale
|
Direct |
2,000
-0.81%
|
$748,000
$374.55 P/Share
|
|
Nov 05
2022
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,164
-2.04%
|
$1,926,172
$373.99 P/Share
|
|
Nov 05
2022
|
Andrew J Greenfield VP, CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,548
-3.15%
|
$577,404
$373.99 P/Share
|
|
Nov 05
2022
|
Marc A Began VP & GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
1,548
-11.23%
|
$577,404
$373.99 P/Share
|
|
Nov 05
2022
|
Todd A Trapp VICE PRESIDENT, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,548
-9.72%
|
$577,404
$373.99 P/Share
|
|
Nov 04
2022
|
Marc A Began VP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
2,000
-12.67%
|
$746,000
$373.71 P/Share
|
|
Nov 01
2022
|
Todd A Trapp VICE PRESIDENT, CFO |
SELL
Open market or private sale
|
Direct |
1,000
-1.51%
|
$379,000
$379.0 P/Share
|
|
Nov 01
2022
|
Paul Thomas |
SELL
Open market or private sale
|
Direct |
1,000
-13.59%
|
$379,000
$379.38 P/Share
|
|
Nov 01
2022
|
Matthew T. Plano VP, GLOBAL OPERATIONS |
SELL
Open market or private sale
|
Direct |
3,544
-7.05%
|
$1,339,632
$379.0 P/Share
|
|
Nov 01
2022
|
Matthew T. Plano VP, GLOBAL OPERATIONS |
BUY
Exercise of conversion of derivative security
|
Direct |
1,843
+11.77%
|
$410,989
$223.9 P/Share
|